Cresco Pharma requests trading halt
Creso Pharma Limited, the company that Creso Pharma, the company focused on cannabis derived therapeutics, requests that its securities to be placed in a trading halt.
Pharmaceuticals, Biotechnology and Life Sciences
Creso Pharma Limited, the company that Creso Pharma, the company focused on cannabis derived therapeutics, requests that its securities to be placed in a trading halt.
Related to Convertible Note and Warrant Programmes established on September 26, 2016 between the Fit Biotech Oy and Bracknor Investment,…
University of Michigan Pancreatic Cancer Center has become the most recent member of the global network of prominent sites participating…
Safe Orthopaedics has started selling a bone substitute for its Walnut cage for cervical surgeries in Europe.
Horizon Discovery has broadened its gene editing capabilities through the amendment of a pre-existing license with ERS Genomics to include…
Joseph Gunnar & Co., LLC, has exercised its over-allotment option to purchase an additional 122,500 common shares from the Akers Biosciences at $1.20 per share with the issuance of a further 61,250 warrants with an exercise price of $1.50 (the Warrants).
BioGaia has signed an exclusive agreement with Abbott for the rights to commercialize BioGaia products in the area of paediatrics and gastroenterology in Thailand.
Weifa has made a deal with New Zealand’s AFT Pharmaceuticals according to which it will sell drugs for pain relief and fever symptoms in the Nordic region (Norway, Sweden, Denmark, Finland and Iceland).
Mainstay Medical International has applied for ReActiv8 to be admitted to the Australian Register of Therapeutic Goods (ARTG) which would…
Pixium Vision, a company developing and commercializing innovative bionic vision systems, has completed 10 implants in its Iris II study.